- Home
- LKSP vs NRXP Comparison
LKSP vs NRXP Comparison
Compare LKSP & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$3.46
Company Overview
Basic Information| Metric | LKSP | NRXP |
|---|---|---|
| Founded | 2024 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.3M | 153.2M |
| IPO Year | 2025 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LKSP | NRXP |
|---|---|---|
| Price | $10.22 | $3.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.25 |
| AVG Volume (30 Days) | 73.7K | ★ 991.4K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 69.70 |
| EPS | ★ 0.09 | N/A |
| Revenue | N/A | ★ $1,225,000.00 |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | N/A | $1,591.73 |
| P/E Ratio | $113.56 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $1.65 |
| 52 Week High | $10.22 | $5.06 |
Technical Indicators
Market Signals| Indicator | LKSP | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 71.63 | 47.48 |
| Support Level | $10.09 | $3.09 |
| Resistance Level | N/A | $3.62 |
| Average True Range (ATR) | 0.00 | 0.21 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 100.00 | 58.35 |
Price Performance
Historical Comparison LKSP
NRXP
About LKSP Lake Superior Acquisition Corp. Class A Ordinary Shares
Lake Superior Acquisition Corp is a blank check company.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.